We report a case of Lichen Sclerosus in a 73-year-old man who had been treated for epilepsy with carbamazepine. Lichen sclerosus et atrophicus (LSA), also called lichen sclerosus (LS), is a chronic inflammatory cutaneous condition characterized by white plaques with epidermal atrophy and scarring. To date no cases of LSA has been linked to carbamazepine, although in a few cases lichenoid eruptions but without sclero-atrophy have been described after exposure to this drug. Therefore, to our knowledge, this is the first report of a Lichen sclerosus et atrophicus induced by carbamazepine
LICHEN SCLEROSUS ET ATROPHICUS INDUCED BY CARBAMAZEPINE: A CASE REPORT / Pranteda, Guglielmo; M., Muscianese; M., Grimaldi; L., Fidanza; G., Pranteda; Narcisi, Alessandra; S., Nistico; Bottoni, Ugo. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 0394-6320. - 26:3(2013), pp. 791-794.
LICHEN SCLEROSUS ET ATROPHICUS INDUCED BY CARBAMAZEPINE: A CASE REPORT
PRANTEDA, Guglielmo;NARCISI, ALESSANDRA;S. Nistico;BOTTONI, Ugo
2013
Abstract
We report a case of Lichen Sclerosus in a 73-year-old man who had been treated for epilepsy with carbamazepine. Lichen sclerosus et atrophicus (LSA), also called lichen sclerosus (LS), is a chronic inflammatory cutaneous condition characterized by white plaques with epidermal atrophy and scarring. To date no cases of LSA has been linked to carbamazepine, although in a few cases lichenoid eruptions but without sclero-atrophy have been described after exposure to this drug. Therefore, to our knowledge, this is the first report of a Lichen sclerosus et atrophicus induced by carbamazepineI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
